Xenetic Biosciences, Inc.
XBIO
$4.11
-$0.17-3.97%
NASDAQ
| 06/30/2026 | 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | |
|---|---|---|---|---|---|
| Revenue | 33.30% | 23.52% | 19.05% | 13.30% | -2.94% |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 33.30% | 23.52% | 19.05% | 13.30% | -2.94% |
| Cost of Revenue | -- | -- | -- | -- | -- |
| Gross Profit | 33.30% | 23.52% | 19.05% | 13.30% | -2.94% |
| SG&A Expenses | 14.22% | -15.49% | -19.64% | -22.59% | -24.31% |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 3.34% | -13.57% | -13.33% | -10.38% | -24.13% |
| Operating Income | 19.11% | 38.27% | 32.58% | 24.09% | 34.80% |
| Income Before Tax | 19.72% | 39.10% | 32.31% | 22.59% | 34.35% |
| Income Tax Expenses | -- | -- | -- | -- | -- |
| Earnings from Continuing Operations | 19.72% | 39.10% | 32.31% | 22.59% | 34.35% |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | 19.72% | 39.10% | 32.31% | 22.59% | 34.35% |
| EBIT | 19.11% | 38.27% | 32.58% | 24.09% | 34.80% |
| EBITDA | -- | -- | -- | -- | -- |
| EPS Basic | 39.94% | 47.80% | 36.62% | 22.68% | 34.51% |
| Normalized Basic EPS | 39.94% | 47.80% | 36.63% | 22.68% | 34.51% |
| EPS Diluted | 39.94% | 47.80% | 36.62% | 22.68% | 34.51% |
| Normalized Diluted EPS | 39.94% | 47.80% | 36.63% | 22.68% | 34.51% |
| Average Basic Shares Outstanding | 34.69% | 22.52% | 10.40% | 0.11% | 0.25% |
| Average Diluted Shares Outstanding | 34.69% | 22.52% | 10.40% | 0.11% | 0.25% |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |